Shear-wave Elastography Diffuse Liver Disease
Correlation Between Shear-wave Elastography and CT in Diffuse Liver Disease
1 other identifier
observational
80
0 countries
N/A
Brief Summary
The aim of this study is to correlate between quantitative results of shear wave elastography and CT picture in diffuse liver disease, including liver cirrhosis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2022
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 6, 2021
CompletedFirst Posted
Study publicly available on registry
December 20, 2021
CompletedStudy Start
First participant enrolled
January 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2023
CompletedJanuary 6, 2022
December 1, 2021
1 year
December 6, 2021
December 17, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Shearwave elastography (SWE) of the liver
Analyze the correlation between SWE of liver and with computed tomography findings.
1 week
Interventions
Shear wave elastography is an ultrasound applied technique used to measure tissue stiffness as a result of a disease. So, it can be used to evaluate liver stiffness as a result of liver cirrhosis
Eligibility Criteria
Patients who diagnosed to had chronic liver diseases with or without present hepatic focal lesions.
You may qualify if:
- Both sexes are included: patients who diagnosed to had chronic liver diseases with or without present hepatic focal lesions.
You may not qualify if:
- Lactating and pregnant women
- Patients known to had high serum creatinine
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (4)
Boll DT, Merkle EM. Diffuse liver disease: strategies for hepatic CT and MR imaging. Radiographics. 2009 Oct;29(6):1591-614. doi: 10.1148/rg.296095513.
PMID: 19959510RESULTLingala S, Ghany MG. Natural History of Hepatitis C. Gastroenterol Clin North Am. 2015 Dec;44(4):717-34. doi: 10.1016/j.gtc.2015.07.003. Epub 2015 Aug 25.
PMID: 26600216RESULTWilkins T, Akhtar M, Gititu E, Jalluri C, Ramirez J. Diagnosis and Management of Hepatitis C. Am Fam Physician. 2015 Jun 15;91(12):835-42.
PMID: 26131943RESULTFerraioli G, Tinelli C, Dal Bello B, Zicchetti M, Filice G, Filice C; Liver Fibrosis Study Group. Accuracy of real-time shear wave elastography for assessing liver fibrosis in chronic hepatitis C: a pilot study. Hepatology. 2012 Dec;56(6):2125-33. doi: 10.1002/hep.25936. Epub 2012 Aug 31.
PMID: 22767302RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Mohamed Abdeltawab, MD
Assiut
- PRINCIPAL INVESTIGATOR
Hayam M Abd El-hakeem
Assiut University
- STUDY CHAIR
Eman Abo El-hamd
Assiut University
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
December 6, 2021
First Posted
December 20, 2021
Study Start
January 1, 2022
Primary Completion
January 1, 2023
Study Completion
February 1, 2023
Last Updated
January 6, 2022
Record last verified: 2021-12
Data Sharing
- IPD Sharing
- Will not share